We are proud to welcome 14 new partners. Learn more about this group of superbly talented lawyers: https://okt.to/bH0V6w
关于我们
From our offices in Beijing, Boston, Brussels, Dubai, Frankfurt, Johannesburg, London, Los Angeles, New York, Palo Alto, San Francisco, Seoul, Shanghai, and Washington, we practice as one firm, holding closely to core values that start with a deep commitment to our clients and the quality of our work on their behalf, and that include an emphasis on teamwork among our lawyers and other professionals and a belief in the obligation of lawyers to make legal services available to all who need them. Our lawyers are recognized nationally and internationally for their legal skills and the depth of their expertise. Many have served in senior government positions. Virtually all of them provide public service through pro bono representation. We are cultivating a diverse, equitable, and inclusive firm that harnesses the abilities of every colleague and the power of diverse perspectives to help clients navigate their most complex business challenges. And because every client is a client of the firm, not of any specific lawyer, every client has the ability to call on any of our lawyers as needed.
- 网站
-
https://www.cov.com
Covington & Burling LLP的外部链接
- 所属行业
- 律师事务所
- 规模
- 1,001-5,000 人
- 总部
- Washington，D.C.
- 类型
- 合营企业
- 创立
- 1919
地点
Covington & Burling LLP员工
动态
-
Congratulations to Dr.iur. Dr.med. Adem Koyuncu who has been shortlisted at the Legal 500 Germany Awards 2025 in the two categories “Lawyer of the Year,” and “Lawyer of the Year: Healthcare.” Find out more: https://okt.to/iKRr5k
-
-
The European Medicines Agency has announced that it will expand its activities under its clinical data publication policy to cover all clinical data submitted under new marketing authorization applications for medicinal products as well as any applications for line extensions or new indications, or where the MAA results in a negative opinion or is otherwise withdrawn. Grant Castle, Robin Blaney, and Roderick Dirkzwager explain: https://okt.to/OwGfbo
-
-
China has issued its Interim Provisions on the Administration of the Designation of Domestic Responsible Person by Overseas Drug Marketing Authorization Holders, which will come into effect on July 1, 2025. Muyun Hu, John Balzano, and Julia Post discuss the rule's effects: https://okt.to/OdVaW2
-
-
The New York Department of Financial Services has issued an industry letter highlighting the cybersecurity risks arising from the use of artificial intelligence and providing strategies to address these risks. While the Guidance “does not impose any new requirements,” it clarifies how Covered Entities should address AI-related risks as part of NYDFS’s landmark cybersecurity regulation, codified at 23 NYCRR Part 500. Here's what you should know: https://okt.to/C5z2IR
-
-
In the latest of a series of blogs on the implementation of Executive Order No. 14110 on the “Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence,” our lawyers discuss key actions taken to implement the AI EO in October 2024: https://okt.to/iqWDmT
-
-
Join our webinar on December 4, where Miriam Guggenheim, Deepti Kulkarni, Jessica Parsons O'Connell, and Jeannie Perron will discuss key post-election considerations for the food and dietary supplement industries in 2025 and beyond. Register now: https://okt.to/IUo6pt
-
-
A recent Court of Common Pleas of Philadelphia County decision marks a rare instance in which a court has ruled upon whether the key elements of a “lottery” or similar gambling scheme were present in a consumer-facing promotional effort. Learn more in this blog post: https://okt.to/LogkZQ
-
-
Join our webinar on December 5 to learn about the tax and benefit issues foreign employers who send employees to work in the United States, either directly or for a foreign affiliate, may face. William Woolston and Michael Chittenden will present practical guidance and tips for employers. Register now: https://okt.to/yg1o2b
-
-
A Covington team led by Brian Rosenzweig and Keunjung (KJ) Cho represented the placement agents in Aclaris Therapeutics’ $80 million private placement: https://okt.to/NQEDfI
-